Evaluation of Predictors Associated with COVID-19 Pneumonia in Rheumatic Patients Using Biological or Targeted Therapies: Results from a Tertiary Center in Turkey
Aim: Disease-related immune dysfunction and/or treatment with immunosuppressive drugs may affect the course of coronavirus disease-2019 (COVID-19) infection in rheumatic patients. The aim of this study was to evaluate the course of COVID-19 infection and predictors of COVID-19 pneumonia in patients...
Main Authors: | Yasemin Ozden Eldemir, Huseyin Kaplan, Senem Sas, Abdurrahman Soner Senel |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-11-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/evaluation-of-predictors-associated-with-covd-19-p/63689
|
Similar Items
-
Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia
by: Yi-Min Huang, et al.
Published: (2022-09-01) -
CT-Severity Analysis of Covid-19 Pneumonia in Rheumatic Musculoskeletal Diseases
by: Ali Murat Koc, et al.
Published: (2021-09-01) -
PNEUMOCYSTIC PNEUMONIA IN RHEUMATIC DISEASES: CURRENT ISSUES IN PROPHYLAXIS
by: B. S. Belov, et al.
Published: (2018-01-01) -
PNEUMOCYSTIC PNEUMONIA IN RHEUMATIC DISEASES: CURRENT ISSUES IN PROPHYLAXIS
by: M. S. Eliseev
Published: (2018-01-01) -
Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China
by: Yu Xue, et al.
Published: (2016-01-01)